Page last updated: 2024-08-25

rosiglitazone and 1-(carboxymethylthio)tetradecane

rosiglitazone has been researched along with 1-(carboxymethylthio)tetradecane in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kuenzli, S; Saurat, JH	1

Trials

1 trial(s) available for rosiglitazone and 1-(carboxymethylthio)tetradecane

Article	Year
Effect of topical PPARbeta/delta and PPARgamma agonists on plaque psoriasis. A pilot study. Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Pilot Projects; Psoriasis; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sulfides; Thiazoles; Thiazolidinediones; Transcription Factors; Treatment Outcome; Vasodilator Agents	2003

Article

Year

Effect of topical PPARbeta/delta and PPARgamma agonists on plaque psoriasis. A pilot study.

Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Pilot Projects; Psoriasis; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sulfides; Thiazoles; Thiazolidinediones; Transcription Factors; Treatment Outcome; Vasodilator Agents

2003